Juniper Pharmaceuticals, Inc.

Juniper Pharmaceuticals’ (Nasdaq: JNP) core businesses include its CRINONE® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end, fee-for-service pharmaceutical development and clinical trials manufacturing to clients.The Company has a successful history in developing pharmaceutical products, including Crinone® 8% (progesterone gel), which is commercially available in the United States and over 90 countries around the world.We provide high end services including pharmaceutical development, clinical trial supply manufacturing, and analytical capabilities to clients, while also providing  valuable intellectual property-related consultative services to our pharmaceutical industry customers.

 

Bank Name Juniper Pharmaceuticals, Inc.
Stock Exchange NASDAQ
Symbol JNP
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman
CEO Ms. Alicia Secor
Employees 155
Website www.juniperpharma.com
Registered Year 1986

 

UpdateContent
UpdateContent
UpdateContent